Impact of External Factors(Brexit and Covid-19) on Retention and Turnover in the NHS

March 10, 2022 updated by: NHS Grampian

The Impact of External Factors (Brexit and Covid 19) on Retention and Turnover Among Nurses and Consultants in NHS Grampian

Problems with retention and staff turnover in the health sectors of many western countries have a long history and have thus attracted research attention over the years. The National Health Service (NHS) in the United Kingdom (UK) is not immune to this problem as it is reported that the NHS as an organisation is struggling to meet staffing demands particularly with its nursing and medical workforce. One of the ways to tackle this problem has been to recruit staffs from European union countries. With the exit of UK from the EU, there are concerns on the this departure on staffing. While the UK was still coming to terms with BREXIT and its effect on the NHS, the current COVID 19 pandemic struck and has intensified workload and demands on the health sector, particularly the NHS. As a result of this, many NHS employees believe more should be done to show they are valued and appreciated for all their hard work. Turnover is already high among clinical occupations in the NHS as people leave for various reasons. It is therefore important to study the combined effect of these external factors (BREXIT and COVID 19) on turnover and retention in the NHS Grampian. It is hoped that this study will be beneficial to NHS Grampian management and policy makers as it will aid early identification of intention to leave and possibly enhance staff retention. The study will be carried out in Scotland and will be limited to NHS Grampian. Nurses and consultants who have been in employed in NHS Grampian prior to BREXIT and COVID 19 will be invited participate. Participants will voluntarily take part in a semi structured interview which may last for about 45 to 60 minutes. The project is self-funded for the award of a PhD in management studies.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United Kingdom
      • Aberdeen, United Kingdom
        • Research and governance team
        • Contact:
          • Louise KIng
          • Phone Number: 01224437220
        • Contact:
          • Phone Number: 01224437220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Nurses who have been trained in different aspects of nursing such as paediatric, neonatal, critical care, surgical, emergency care etc and consultants who have specialist training in specific aspect of medicine who have had to deal with the impact and pressures of COVID 19 and BREXIT will be invited to participate in the study.

Description

Inclusion Criteria:

  • Must be employed in NHS Grampian prior to January 2020.
  • Must be a Nurse or Consultant

Exclusion Criteria:

  • Limited to Nurses and Consultants.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Non clinical procedure
Completion of consent form and interview session
Other: Non Clinical procedure
Non clinical procedure- Informed consent completion and interview session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Participants will be interviewed to assess the impact of external factors on retention and turnover.
Time Frame: 45- 60 minutes
45- 60 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Interviews with 40 participants will be analysed using NVivo qualitative software.
Time Frame: 45-60minutes
45-60minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NHS Grampian

Investigators

  • Principal Investigator: Donald Hislop, University of Aberdeen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2022

Primary Completion (Anticipated)

August 31, 2023

Study Completion (Anticipated)

August 31, 2023

Study Registration Dates

First Submitted

February 8, 2022

First Submitted That Met QC Criteria

March 10, 2022

First Posted (Actual)

March 11, 2022

Study Record Updates

Last Update Posted (Actual)

March 11, 2022

Last Update Submitted That Met QC Criteria

March 10, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2-083-21

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Impact of BREXIT & COVID 19 on Retention and Turnover on NHS

Clinical Trials on Non Clinical procedure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe